This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Association between serum levels of testosterone and estradiol with meibomian gland assessments in postmenopausal women

Association between serum levels of testosterone and estradiol with meibomian gland assessments in postmenopausal women
Reviewed by Wai Siene Ng

1 April 2016 | Wai Siene Ng | EYE - Oculoplastic, EYE - Orbit

This study aims to reveal any correlation between serum levels of testosterone and estradiol in postmenopausal women with meibomian gland dysfunction. Postmenopausal subjects were defined as amenorrhoea for at least one year with low follide stimulating hormone (FSH) and estradiol. Exclusion criteria include ocular surgery within the previous year and any anterior segment disease. However, women on hormone replacement therapy were included. To demonstrate any effect from this a subgroup analysis was performed which showed no difference. Meibomian gland assessments included in the study were expressibility of meibum, meibum quality, meibomian gland dropout by and lipid layer thickness by spectral interferometry. Estradiol and testosterone serum levels were taken from venous blood samples. However, the time of blood sampling was not described which may be pertinent due to the diurnal variations of hormones and their well-reported bias effect if not taken into account. The authors also proceed to divide the cohort into dry eye or normal based on a Schaumberg questionnaire. However, as the questionnaire relies on the patient self-reporting a diagnosis of dry eye, its validity is questionable. The only objective outcome in the meibomian gland assessments was lipid layer thickness. However, this returned a contradicting result with the dry eye group having a thicker lipid layer. The rest of the assessments were subjective and lacked assessor method description and validation. Hence, it comes as no surprise that there was no significant difference found in estradiol levels and testosterone levels for dry eye of meibomian gland assessment apart from that seen between severe and mild meibomian gland dropout cases and increased testosterone levels. Overall, the study attempts to address the relation between postmenopausal dry eye and meibomian gland dysfunction with estradiol and testosterone with in depth meibomian gland analysis. Improvement in the diagnostic criteria for dry eyes and consistent times for obtaining blood samples may help reveal subtle associations between sex hormones and postmenopausal dry eyes in future studies. 

Association between serum levels of testosterone and estradiol with meibomian gland assessments in postmenopausal women.
Ablamowicz AF, Nichols JJ, Nichols KK.
INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE
2016;57:295-300.
Share This
CONTRIBUTOR
Wai Siene Ng

University Hospital of Wales, Cardiff, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency